Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention

Spyridon Kostantinis; Athanasios Rempakos; Bahadir Simsek; Judit Karacsonyi; Salman S. Allana; Michaella Alexandrou; Rhian E. Davies; Bavana Venkata Rangan; Yader Sandoval; Emmanouil S. Brilakis

doi:10.1016/j.jcin.2023.06.038

Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention

Spyridon Kostantinis, Athanasios Rempakos, Bahadir Simsek, Judit Karacsonyi, Salman S. Allana, Michaella Alexandrou, Rhian E. Davies, Bavana Venkata Rangan, Yader Sandoval, Emmanouil S. Brilakis

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2475-2477
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	16
Issue number	19
DOIs	https://doi.org/10.1016/j.jcin.2023.06.038
State	Published - Oct 9 2023

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2023.06.038

Cite this

Kostantinis, S., Rempakos, A., Simsek, B., Karacsonyi, J., Allana, S. S., Alexandrou, M., Davies, R. E., Rangan, B. V., Sandoval, Y., & Brilakis, E. S. (2023). Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 16(19), 2475-2477. https://doi.org/10.1016/j.jcin.2023.06.038

@article{08f6b69f6bf24de8b9ca9f20f156c2f1,

title = "Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention",

author = "Spyridon Kostantinis and Athanasios Rempakos and Bahadir Simsek and Judit Karacsonyi and Allana, {Salman S.} and Michaella Alexandrou and Davies, {Rhian E.} and Rangan, {Bavana Venkata} and Yader Sandoval and Brilakis, {Emmanouil S.}",

note = "Funding Information: This study was funded through the philanthropic support of generous anonymous donors and of Drs. Mary Ann and Donald A. Sens, Mrs. Diane and Dr. Cline Hickok, Mrs. Wilma and Mr. Dale Johnson, the Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund, the Roehl Family Foundation, and the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation{\textquoteright}s Science Center for Coronary Artery Disease helped support this research project. Dr. Allana is a consultant for Boston Scientific and Abiomed. Dr. Davies has received speaking honoraria form Abiomed, Asahi Intecc, Boston Scientific, Medtronic, Shockwave, and Teleflex; and serves on advisory boards for Abiomed, Avinger, Boston Scientific, Medtronic, and Rampart. Dr. Sandoval has previously served on advisory boards for Roche Diagnostics and Abbott Diagnostics, without personal compensation; and has also been a speaker, without personal financial compensation, for Abbott Diagnostics. Dr. Brilakis has received consulting and speaker honoraria from Abbott Vascular, the American Heart Association (associate editor, Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, the Cardiovascular Innovations Foundation (Board of Directors), ControlRad, Cardiovascular Systems, Elsevier, GE Healthcare, IMDS, Infraredx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; has received research support from Boston Scientific and GE Healthcare; is an owner of Hippocrates; and is a shareholder in MHI Ventures, Cleerly Health, and Stallion Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2023",

month = oct,

day = "9",

doi = "10.1016/j.jcin.2023.06.038",

language = "English (US)",

volume = "16",

pages = "2475--2477",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "19",

}

TY - JOUR

T1 - Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention

AU - Kostantinis, Spyridon

AU - Rempakos, Athanasios

AU - Simsek, Bahadir

AU - Karacsonyi, Judit

AU - Allana, Salman S.

AU - Alexandrou, Michaella

AU - Davies, Rhian E.

AU - Rangan, Bavana Venkata

AU - Sandoval, Yader

AU - Brilakis, Emmanouil S.

N1 - Funding Information: This study was funded through the philanthropic support of generous anonymous donors and of Drs. Mary Ann and Donald A. Sens, Mrs. Diane and Dr. Cline Hickok, Mrs. Wilma and Mr. Dale Johnson, the Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund, the Roehl Family Foundation, and the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation’s Science Center for Coronary Artery Disease helped support this research project. Dr. Allana is a consultant for Boston Scientific and Abiomed. Dr. Davies has received speaking honoraria form Abiomed, Asahi Intecc, Boston Scientific, Medtronic, Shockwave, and Teleflex; and serves on advisory boards for Abiomed, Avinger, Boston Scientific, Medtronic, and Rampart. Dr. Sandoval has previously served on advisory boards for Roche Diagnostics and Abbott Diagnostics, without personal compensation; and has also been a speaker, without personal financial compensation, for Abbott Diagnostics. Dr. Brilakis has received consulting and speaker honoraria from Abbott Vascular, the American Heart Association (associate editor, Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, the Cardiovascular Innovations Foundation (Board of Directors), ControlRad, Cardiovascular Systems, Elsevier, GE Healthcare, IMDS, Infraredx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; has received research support from Boston Scientific and GE Healthcare; is an owner of Hippocrates; and is a shareholder in MHI Ventures, Cleerly Health, and Stallion Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2023/10/9

Y1 - 2023/10/9

UR - http://www.scopus.com/inward/record.url?scp=85172190675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85172190675&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2023.06.038

DO - 10.1016/j.jcin.2023.06.038

M3 - Letter

C2 - 37821191

AN - SCOPUS:85172190675

SN - 1936-8798

VL - 16

SP - 2475

EP - 2477

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 19

ER -

Temporal Trends of Calcium Modification Therapies in Chronic Total Occlusion Percutaneous Coronary Intervention

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this